💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Galmed Pharmaceuticals Ltd. (GLMD)
« Back to company indexGLMD Chatter Timeline
Stock Ticker for GLMD
Most Active Tweeters for GLMD
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @PennySearch | 7 |
| @TheMarketsDaily | 2 |
| @mediasentiment | 2 |
| @newsfilterio | 2 |
Recent Tweets for GLMD
 |
@alerts_real $GLMD All that you need to know... Shorts haven't covered a single share https://t.co/6YesXV6dRW January 24th 2022, 4:01pm |
 |
@Tickeron $GLMD's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/hdQfWEyjZ4 January 24th 2022, 12:01am |
 |
@ChartMill $GLMD is valued rather cheaply when comparing the Enterprise Value to EBITDA ratio to the industry average of 1.53.… https://t.co/L6QuBQCyrb January 22nd 2022, 1:01am |
 |
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/LbIczYCTY8 January 21st 2022, 8:01am |
 |
@newsfilterio SUDA Pharmaceuticals Ltd - Appeal, Reversed $GLMD https://t.co/NYaLNmKPpa January 20th 2022, 6:01pm |
|
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/Iyxw9llxd8 January 20th 2022, 8:01am |
|
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/GVY8UpDUgz January 19th 2022, 2:01pm |
|
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/UJ4A9tRqw2 January 19th 2022, 5:01am |
|
@Tickeron $GLMD enters a Downtrend as Momentum Indicator dropped below the 0 level on January 5, 2022. View odds for this and… https://t.co/sAO1VivyWu January 17th 2022, 6:01pm |
|
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/wEp0mIVAD8 January 16th 2022, 4:01am |
|
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/fmpc1jHDgC January 15th 2022, 12:01am |
|
@Tickeron $GLMD's Aroon indicator drops into Downtrend on January 13, 2022. View odds for this and other indicators:… https://t.co/SE9Er4IWTr January 14th 2022, 8:01am |
|
@Tickeron How does this make you feel? $GLMD Aroon Indicator entered a Downtrend. #GalmedPharmaceuticals… https://t.co/cqCcQIjQSJ January 14th 2022, 8:01am |
|
@Tickeron This is amazing! What do you think? $GLMD RSI Indicator left the oversold zone. #GalmedPharmaceuticals… https://t.co/PzdLQMcMta January 14th 2022, 7:01am |
|
@Tickeron $GLMD enters a Downtrend as Momentum Indicator dropped below the 0 level on January 5, 2022. View odds for this and… https://t.co/X1GKdTWvmp January 14th 2022, 3:01am |
|
@Tickeron How does this make you feel? $GLMD Aroon Indicator entered a Downtrend. #GalmedPharmaceuticals… https://t.co/0pQao5wI3l January 13th 2022, 9:01pm |
 |
@mediasentiment $GLMD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 202 January 13th 2022, 10:01am |
|
@mediasentiment $GLMD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 200 January 13th 2022, 10:01am |
 |
@TheMarketsDaily Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research to “Sell” https://t.co/Ajhu2CC9LA January 13th 2022, 10:01am |
|
@TheMarketsDaily Galmed Pharmaceuticals $GLMD Lowered to “Sell” at Zacks Investment Research https://t.co/gSvVxfunXj January 13th 2022, 10:01am |
 |
@kwhenfinance Galmed Pharmaceuticals Ltd Shares Close the Week 21.3% Lower - Weekly Wrap https://t.co/lIJCdItBCi $GLMD #stockmarket #kwhenfinance January 12th 2022, 9:01am |
|
@PennySearch $GLMD Canaccord Genuity gave GLMD a Buy stock rating on 2021-05-17. Find top penny stocks with PennySearch befor… https://t.co/oiKxt3FiA3 January 12th 2022, 3:01am |
|
@newsfilterio Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt $GLMD https://t.co/Npv3lkVKth January 12th 2022, 3:01am |
 |
@Sarah_Katiilyn RT @Sarah_Katilyn: $GLMD I've followed and traded this for a bit now. Their Nash trial marches on and 3 new US patents. Not sure it'll move… January 12th 2022, 12:01am |
 |
@GetOnTrade $GLMD Galmed Announces New Patents For Aramchol And Its Meglumine Salt https://t.co/b0Gzrtlknq January 11th 2022, 9:01pm |
|
@GetOnTrade $GLMD Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt https://t.co/k7uRtfv6se January 11th 2022, 9:01pm |
 |
@MaiteMerenda $GLMD Almost ripe for a run Chart by https://t.co/t5kOjgsWN3 https://t.co/SeY2gwbiHc January 11th 2022, 4:01pm |
 |
@shortablestocks $GLMD is short sale restricted for 2022-01-11. https://t.co/46TkDKlRFk January 11th 2022, 2:01pm |
 |
@mehabecapital $GLMD @ 1.63 (-13.53%) : Galmed gains 5% after securing three new U.S. patents for Aramchol and meglumine salt https://t.co/Nvj3iNQxy3 January 11th 2022, 1:01pm |
 |
@Sarah_Katilyn $GLMD I've followed and traded this for a bit now. Their Nash trial marches on and 3 new US patents. Not sure it'll… https://t.co/NMyNFF5sFi January 11th 2022, 1:01pm |
 |
@Gambiste1 RT @WSBConsensus: Galmed Pharmaceuticals ( $GLMD ) received three new patents from the U.S. Patent and Trademark Office for treatment of pa… January 11th 2022, 1:01pm |
|
@GetOnTrade $GLMD Galmed Pharmaceuticals Ltd Shares Fall 5.2% Below Previous 52Week Low Market Mover Nasdaq https://t.co/pbWjc6oSEo January 11th 2022, 1:01pm |
 |
@soloalam1 RT @MarketCurrents: $GLMD - Galmed gains 5% after securing three new U.S. patents for Aramchol and meglumine salt https://t.co/DwzRdlphBh January 11th 2022, 1:01pm |
 |
@MarketCurrents $GLMD - Galmed gains 5% after securing three new U.S. patents for Aramchol and meglumine salt https://t.co/DwzRdlphBh January 11th 2022, 1:01pm |
 |
@WSBConsensus Galmed Pharmaceuticals ( $GLMD ) received three new patents from the U.S. Patent and Trademark Office for treatment… https://t.co/tZf4yIB9qX January 11th 2022, 1:01pm |
 |
@quantisnow $GLMD ? SEC Form 6-K filed by Galmed Pharmaceuticals Ltd. https://t.co/5dt3PGKkWe 45 seconds delayed. January 11th 2022, 1:01pm |
 |
@investor_feed $GLMD 6-K Galmed Pharmaceuticals (11 Jan, 8:15am) ? Galmed Continues to Drive Innovation with Three New US Pat… https://t.co/kbfluh1Asi January 11th 2022, 1:01pm |
 |
@A1Syad $GLMD Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/t1OgrL1pTb January 11th 2022, 12:01pm |
 |
@OryoJohn $GLMD Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt… https://t.co/ohOJ2Qdiac January 11th 2022, 12:01pm |
 |
@vtmtrading Galmed awarded three Aramchol related patents by USPTO $GLMD January 11th 2022, 12:01pm |
 |
@FlashAlert_me $GLMD [15s. delayed]: Issued Press Release on January 11, 07:30:00: Galmed Continues to Drive Innovation with Three… https://t.co/wGolI8mvp0 January 11th 2022, 12:01pm |
 |
@James__BondOO7 RT @stock_titan: $GLMD Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt https://t… January 11th 2022, 12:01pm |
 |
@StockNewsBot2 $GLMD Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt https://t.co/FvsM9txzVb January 11th 2022, 12:01pm |
 |
@stock_titan $GLMD Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt… https://t.co/vqIKOmeTXA January 11th 2022, 12:01pm |
 |
@WebChronicleTo1 $GLMD Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt https://t.co/df2NfxFVJ0 January 11th 2022, 12:01pm |
 |
@LeeSinTrade1 $GLMD Waiting for Buy signal on GLMD with https://t.co/yV6BCXxMw6 https://t.co/WOl5uKhsLe January 11th 2022, 12:01pm |
|
@Tickeron $GLMD's Aroon indicator drops into Downtrend on January 10, 2022. View odds for this and other indicators:… https://t.co/90MEM57yjb January 11th 2022, 12:01pm |
|
@Tickeron This is why Hedge Funds use A.I. $GLMD price may climb as it broke lower Bollinger Band. #GalmedPharmaceuticals… https://t.co/zYzpCRfkuj January 11th 2022, 11:01am |
|
@Tickeron If you’re trading this week, Read This! $GLMD Aroon Indicator entered a Downtrend. #GalmedPharmaceuticals… https://t.co/CKfreotm1t January 11th 2022, 10:01am |
|
@Tickeron What do you think of this? $GLMD The volume increased for one day, resulting in a record-breaking daily growth of 1… https://t.co/l3yNDfhXS1 January 11th 2022, 10:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?